ArticleCurrent oncology (Toronto, Ont.)2021

Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs.

Ronak Saluja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.